NEUROGINE

Neurogine Capital (L) Ltd LL15607 is regulated and licensed by Labuan Financial Services Authority (LFSA) to provide money brokering activities (Labuan Money-Broking License MB/19/0033) since May 2019. Neurogine Capital is part of Neurogine Group aiming to provide a common cross-border mobile banking, payment and investment platform in South East Asia.

In 2019, Neurogine Capital launched nTrade®, an investment trading and money broking platform.

This service is meant for money brokers, investment managers, fund operators, financial institutions and banks. It comprises the use of fiat currencies (e.g. USD, EUR, RMB and SGD) and digital currencies (e.g. BTC, ETH, LTC and USDT). nTrade® uses dynamic Intelligent Order Routing (IOR) engine to access and aggregate several Decentralised Financial (DeFi) exchanges for true price visibility on more than 51,000 pairs, the largest of its kind in South East Asia.

Apart from nTrade®’s Know-Your-Customer processes, Neurogine Capital has further strengthened its Anti Money Laundering/ Counter Finance Terrorism (AML/ CFT) processes by investing in additional steps of collaborating with three global end-to-end identity verification and authentication operators to ensure a smooth and uninterrupted on-boarding timeline of 72-hours.

Neurogine Capital is located in Labuan, Malaysia and a fully owned subsidiary and controlled by Neurogine Sdn. Bhd. 1096943-U.